Omnicomm Systems Inc (OMCM) 0.2000 $OMCM
OmniComm Systems(R) Announces Reseller Agreement With Tri-I Biotech Shanghai Inc.
Marketwired - Fri Jul 10, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology and services, today announced that it has signed a reselling partnership agreement with Tri-I Biotech Shanghai Inc., a market leading China based consultancy providing high performance informatics solutions to over 1,000 medical and clinical research organizations across China, Hong Kong, Macau and Taiwan.
OmniComm Systems Common Stock Upgrades to Trade on OTCQX Best Marketplace
Marketwired - Wed Jul 01, 6:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announced today that it will begin trading on the OTCQX® Best Marketplace for established global and growth companies operated by OTC Markets Group Inc. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
OTC Markets Group Welcomes OmniComm Systems, Inc. to OTCQX
PR Newswire - Wed Jul 01, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced OmniComm Systems, Inc. (OTCQX: OMCM), a leading strategic software solutions provider to the life sciences industry, has qualified to trade on the OTCQX® Best Marketplace.
OmniComm Systems(R) Expands Presence in Japan and Philippines
Marketwired - Mon Jun 15, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the selection of Promasys® EDC by Integrated Development Associates (IDA), a Tokyo-based Pan Asian drug development company, to run clinical trials in Japan and the Philippines. Japan represents the second largest pharmaceutical market in the world whereas the Philippines is one of the fastest growing markets.
Leading Global Biopharmaceutical Selects TrialMaster(R) EDC for CNS Drug Trials
Marketwired - Tue Jun 09, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of electronic data capture and clinical data management technology, announces that a global biopharmaceutical company has selected TrialMaster EDC for nine clinical studies spanning several different central nervous system (CNS) drug programs.
Global E-Clinical Solutions Market Outlook 2020 - Technological Advancements Reducing the Cost of Clinical Testing
M2 - Tue May 19, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cdnw6c/global_eclinical) has announced the addition of the "Global E-Clinical Solutions Market Outlook 2020" report to their offering. The introduction of e-clinical solutions to the global market was aimed at increasing the efficiency and cost effectiveness of the whole drug development process, in particular during the clinical phases. Previously, clinical testing of new drugs was a complex, lengthy and expensive process, but through e-clinical solutions, clinical data can be efficiently and securely transferred among providers at a much lower cost. This shift in technology has revolutionized the entire clinical trial industry. The e-clinical solution market is witnessing rapid expansion due to increasing amount of R&D investments in pharmaceuticals and growing number of clinical trials and it is estimated to grow at a CAGR of around 15% during 2015-2020. In the report Global E-Clinical Solutions Market Outlook 2020, the analysts have identified and described the market dynamics in important segments thus clearly highlighting the areas offering promising growth potentials for companies to boost their expansion. On studying the market thoroughly, we observed that the trends like increasing number of clinical trials, rising investment into clinical research and development, and technological advancements raising the affordability of clinical testing are propelling the demand for e-clinical solutions worldwide. Our study also revealed that although North America and Europe hold the maximum share in the international front, a spurring demand in the Asia-Pacific region is driving the global e-clinical solutions market further. In the report, the market size has been studied in two major segments, by application and by services. Our analysis deciphers that e-clinical applications like CTMS, CDMS, ECOA and RTSM are the major driving forces behind the growth of the e-clinical solution industry. The report also discusses about the growth potential of end-users' market that includes pharmaceutical, CROs and healthcare service providers. It provides a vivid description of the mode of delivery of e-clinical software solutions that is based on web-hosted, on-premise and cloud based methods. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Clinical Trials Industry - An Overview 4. Industry Trends and Drivers 5. E-Clinical Solutions Market Outlook to 2020 6. Regional Analysis - Current and Future Potential 7. Key Players - Almac Group - ArisGlobal - BioClinica - DATATRAK International Inc - ERT - Medidata Solutions - Merge Healthcare Incorporated - OmniComm Systems Inc. - Oracle Corporation - PAREXEL International Corporation For more information visit http://www.researchandmarkets.com/research/cd..._eclinical
PRXL: 65.75 (+1.36), MDSO: 55.54 (+1.44), MRGE: 4.84 (+0.21), ORCL: 40.36 (+0.18)
OmniComm Systems Announces Innovative New Release of TrialMaster(R) EDC
Marketwired - Wed Apr 01, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the general availability of release 4.2.1 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This release provides new capabilities to capture audit trail information for electronic source data, dramatic productivity enhancements in the automated generation of SDTM datasets, the ability for sites in registry studies to export their own data, and over 100 other targeted enhancements. This release also contains performance improvements that allow TrialMaster to effortlessly support the industry's biggest studies.
Improving ECG Data Quality and Availability: Automatic Transmission of Data From Devices Into eSource Systems, New Webinar Hosted by Xtalks
Marketwired - Wed Mar 25, 6:05AM CDT
Join presenters Mark Mentzer, Vice President of Strategic Partnerships at Mortara Instrument, and Michelle King, Director of Early Phase Consulting at OmniComm Systems, Inc. for a complementary webinar and learn how OmniComm and Mortara use the bi-directional communication between Mortara ECG devices and the TrialOne® eSource system to automatically transmit information between the two, and how the implementation of direct data capture is able to improve clinical trial data quality and availability. There will be two live broadcasts on Tuesday, April 21, 2015, at 9am EDT (2pm BST /GMT +1), and 11am EDT.
E-Clinical Trial Technologies - Global Strategic Business Report 2015-2020: Electronic Patient Record (ePRO) Solutions Fast Replacing Paper-Based PRO Systems
M2 - Wed Mar 25, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d4nrg7/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a three-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Segments: - Electronic Data Capture (EDC) Solutions - Clinical Trial Management System (CTMS) - Electronic Patient Reported Outcome (ePRO) - Randomization and Trial Supply Management (RTSM) The report profiles 85 companies including many key and niche players such as: - Almac Group (UK) - ArisGlobal LLC (US) - BioClinica (US) - Clinipace Worldwide (US) - Cmed Technology Ltd (UK) - DATATRAK International, Inc. (US) - DSG Inc. (US) - DZS Software Solutions, Inc. (US) - eClinForce, Inc (US) - eClinical Insights, Inc. (US) - eResearch Technology, Inc. (US) - Integrated Clinical Solutions, Inc. (US) - Medidata Solutions, Inc. (US) - MedNet Solutions (US) - Merge Healthcare, Inc. (US) - Nextrials Inc. (US) - OmniComm Systems, Inc. (US) - Oracle Health Sciences (US) - PAREXEL International Corp. (US) - Perceptive Informatics, Inc. (US) - PHT Corp. (US) - Prelude Dynamics LLC (US) - SAS Institute Inc. (US) - Target Health Inc. (US) - Trianz Solutions (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. COMPETITIVE LANDSCAPE 4. PRODUCT PROFILE 5. PRODUCT/SERVICE INTRODUCTIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 85 (including Divisions/Subsidiaries - 92) - The United States (58) - Canada (2) - Japan (1) - Europe (27) - - France (2) - - Germany (3) - - The United Kingdom (12) - - Italy (2) - - Rest of Europe (
- Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/d4...ical_trial
PRXL: 65.75 (+1.36), MDSO: 55.54 (+1.44), MRGE: 4.84 (+0.21)
Veloxis Pharmaceuticals Chooses TrialMaster(R) EDC for Risk-Based Monitoring
Marketwired - Wed Mar 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that after a rigorous evaluation process of various commercially available EDC technologies, Veloxis selected TrialMaster EDC to run its Phase IV clinical studies.
OmniComm Systems(R) TrialOne(R) Suite Selected by ICON for Phase I Clinic Automation
Marketwired - Tue Mar 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced the signing of a multi-year agreement with ICON for OmniComm Systems' market leading TrialOne technology for Phase I clinic automation. ICON is one of the world's largest contract research organizations (CROs) with around 10,600 employees in 38 countries. ICON provides drug development solutions and services on a global basis to the pharmaceutical, biotechnology, and medical device industries supporting all stages of the clinical development process.
OmniComm Systems Appoints General Manager of China; Mr. Feng Cheng Focuses on Expanding Growth and Business Operations
Marketwired - Mon Feb 09, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the appointment of Mr. Feng Cheng as general manager of OmniComm, China. Mr. Cheng will lead OmniComm's long-term regional strategy, identifying and developing business expansion and growth initiatives.
OmniComm Systems buys interactive response technology assets from ClinQuest for undisclosed amount
M2 - Mon Feb 09, 5:34AM CST
OmniComm Systems (OTCQB:OMCM), a provider of software solutions provider to the life sciences industry, revealed on Friday that it has completed the acquisition of the interactive response technology (IRT) assets from ClinQuest, a healthcare product development service provider.
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value
Marketwired - Fri Jan 16, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces record growth in total contract value for 2014. Total contract value grew over 141% from 2013. A significant portion, 33%, of total contract value, came from companies that are within the 10 largest global contract research organizations (CRO) and pharmaceutical companies. The company experienced healthy year-over-year contract value growth from new and existing clients, 388% and 51% respectively.
OmniComm Systems(R) Announces Reseller Agreement With Tri-I Biotech Shanghai Inc.
Marketwired - Fri Jul 10, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology and services, today announced that it has signed a reselling partnership agreement with Tri-I Biotech Shanghai Inc., a market leading China based consultancy providing high performance informatics solutions to over 1,000 medical and clinical research organizations across China, Hong Kong, Macau and Taiwan.
OmniComm Systems Common Stock Upgrades to Trade on OTCQX Best Marketplace
Marketwired - Wed Jul 01, 6:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announced today that it will begin trading on the OTCQX® Best Marketplace for established global and growth companies operated by OTC Markets Group Inc. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
OTC Markets Group Welcomes OmniComm Systems, Inc. to OTCQX
PR Newswire - Wed Jul 01, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced OmniComm Systems, Inc. (OTCQX: OMCM), a leading strategic software solutions provider to the life sciences industry, has qualified to trade on the OTCQX® Best Marketplace.
OmniComm Systems(R) Expands Presence in Japan and Philippines
Marketwired - Mon Jun 15, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the selection of Promasys® EDC by Integrated Development Associates (IDA), a Tokyo-based Pan Asian drug development company, to run clinical trials in Japan and the Philippines. Japan represents the second largest pharmaceutical market in the world whereas the Philippines is one of the fastest growing markets.
Leading Global Biopharmaceutical Selects TrialMaster(R) EDC for CNS Drug Trials
Marketwired - Tue Jun 09, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of electronic data capture and clinical data management technology, announces that a global biopharmaceutical company has selected TrialMaster EDC for nine clinical studies spanning several different central nervous system (CNS) drug programs.
Global E-Clinical Solutions Market Outlook 2020 - Technological Advancements Reducing the Cost of Clinical Testing
M2 - Tue May 19, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cdnw6c/global_eclinical) has announced the addition of the "Global E-Clinical Solutions Market Outlook 2020" report to their offering. The introduction of e-clinical solutions to the global market was aimed at increasing the efficiency and cost effectiveness of the whole drug development process, in particular during the clinical phases. Previously, clinical testing of new drugs was a complex, lengthy and expensive process, but through e-clinical solutions, clinical data can be efficiently and securely transferred among providers at a much lower cost. This shift in technology has revolutionized the entire clinical trial industry. The e-clinical solution market is witnessing rapid expansion due to increasing amount of R&D investments in pharmaceuticals and growing number of clinical trials and it is estimated to grow at a CAGR of around 15% during 2015-2020. In the report Global E-Clinical Solutions Market Outlook 2020, the analysts have identified and described the market dynamics in important segments thus clearly highlighting the areas offering promising growth potentials for companies to boost their expansion. On studying the market thoroughly, we observed that the trends like increasing number of clinical trials, rising investment into clinical research and development, and technological advancements raising the affordability of clinical testing are propelling the demand for e-clinical solutions worldwide. Our study also revealed that although North America and Europe hold the maximum share in the international front, a spurring demand in the Asia-Pacific region is driving the global e-clinical solutions market further. In the report, the market size has been studied in two major segments, by application and by services. Our analysis deciphers that e-clinical applications like CTMS, CDMS, ECOA and RTSM are the major driving forces behind the growth of the e-clinical solution industry. The report also discusses about the growth potential of end-users' market that includes pharmaceutical, CROs and healthcare service providers. It provides a vivid description of the mode of delivery of e-clinical software solutions that is based on web-hosted, on-premise and cloud based methods. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Clinical Trials Industry - An Overview 4. Industry Trends and Drivers 5. E-Clinical Solutions Market Outlook to 2020 6. Regional Analysis - Current and Future Potential 7. Key Players - Almac Group - ArisGlobal - BioClinica - DATATRAK International Inc - ERT - Medidata Solutions - Merge Healthcare Incorporated - OmniComm Systems Inc. - Oracle Corporation - PAREXEL International Corporation For more information visit http://www.researchandmarkets.com/research/cd..._eclinical
PRXL: 65.75 (+1.36), MDSO: 55.54 (+1.44), MRGE: 4.84 (+0.21), ORCL: 40.36 (+0.18)
OmniComm Systems Announces Innovative New Release of TrialMaster(R) EDC
Marketwired - Wed Apr 01, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the general availability of release 4.2.1 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This release provides new capabilities to capture audit trail information for electronic source data, dramatic productivity enhancements in the automated generation of SDTM datasets, the ability for sites in registry studies to export their own data, and over 100 other targeted enhancements. This release also contains performance improvements that allow TrialMaster to effortlessly support the industry's biggest studies.
Improving ECG Data Quality and Availability: Automatic Transmission of Data From Devices Into eSource Systems, New Webinar Hosted by Xtalks
Marketwired - Wed Mar 25, 6:05AM CDT
Join presenters Mark Mentzer, Vice President of Strategic Partnerships at Mortara Instrument, and Michelle King, Director of Early Phase Consulting at OmniComm Systems, Inc. for a complementary webinar and learn how OmniComm and Mortara use the bi-directional communication between Mortara ECG devices and the TrialOne® eSource system to automatically transmit information between the two, and how the implementation of direct data capture is able to improve clinical trial data quality and availability. There will be two live broadcasts on Tuesday, April 21, 2015, at 9am EDT (2pm BST /GMT +1), and 11am EDT.
E-Clinical Trial Technologies - Global Strategic Business Report 2015-2020: Electronic Patient Record (ePRO) Solutions Fast Replacing Paper-Based PRO Systems
M2 - Wed Mar 25, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d4nrg7/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a three-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Segments: - Electronic Data Capture (EDC) Solutions - Clinical Trial Management System (CTMS) - Electronic Patient Reported Outcome (ePRO) - Randomization and Trial Supply Management (RTSM) The report profiles 85 companies including many key and niche players such as: - Almac Group (UK) - ArisGlobal LLC (US) - BioClinica (US) - Clinipace Worldwide (US) - Cmed Technology Ltd (UK) - DATATRAK International, Inc. (US) - DSG Inc. (US) - DZS Software Solutions, Inc. (US) - eClinForce, Inc (US) - eClinical Insights, Inc. (US) - eResearch Technology, Inc. (US) - Integrated Clinical Solutions, Inc. (US) - Medidata Solutions, Inc. (US) - MedNet Solutions (US) - Merge Healthcare, Inc. (US) - Nextrials Inc. (US) - OmniComm Systems, Inc. (US) - Oracle Health Sciences (US) - PAREXEL International Corp. (US) - Perceptive Informatics, Inc. (US) - PHT Corp. (US) - Prelude Dynamics LLC (US) - SAS Institute Inc. (US) - Target Health Inc. (US) - Trianz Solutions (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. COMPETITIVE LANDSCAPE 4. PRODUCT PROFILE 5. PRODUCT/SERVICE INTRODUCTIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 85 (including Divisions/Subsidiaries - 92) - The United States (58) - Canada (2) - Japan (1) - Europe (27) - - France (2) - - Germany (3) - - The United Kingdom (12) - - Italy (2) - - Rest of Europe (
- Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/d4...ical_trial PRXL: 65.75 (+1.36), MDSO: 55.54 (+1.44), MRGE: 4.84 (+0.21)
Veloxis Pharmaceuticals Chooses TrialMaster(R) EDC for Risk-Based Monitoring
Marketwired - Wed Mar 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that after a rigorous evaluation process of various commercially available EDC technologies, Veloxis selected TrialMaster EDC to run its Phase IV clinical studies.
OmniComm Systems(R) TrialOne(R) Suite Selected by ICON for Phase I Clinic Automation
Marketwired - Tue Mar 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced the signing of a multi-year agreement with ICON for OmniComm Systems' market leading TrialOne technology for Phase I clinic automation. ICON is one of the world's largest contract research organizations (CROs) with around 10,600 employees in 38 countries. ICON provides drug development solutions and services on a global basis to the pharmaceutical, biotechnology, and medical device industries supporting all stages of the clinical development process.
OmniComm Systems Appoints General Manager of China; Mr. Feng Cheng Focuses on Expanding Growth and Business Operations
Marketwired - Mon Feb 09, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the appointment of Mr. Feng Cheng as general manager of OmniComm, China. Mr. Cheng will lead OmniComm's long-term regional strategy, identifying and developing business expansion and growth initiatives.
OmniComm Systems buys interactive response technology assets from ClinQuest for undisclosed amount
M2 - Mon Feb 09, 5:34AM CST
OmniComm Systems (OTCQB:OMCM), a provider of software solutions provider to the life sciences industry, revealed on Friday that it has completed the acquisition of the interactive response technology (IRT) assets from ClinQuest, a healthcare product development service provider.
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value
Marketwired - Fri Jan 16, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces record growth in total contract value for 2014. Total contract value grew over 141% from 2013. A significant portion, 33%, of total contract value, came from companies that are within the 10 largest global contract research organizations (CRO) and pharmaceutical companies. The company experienced healthy year-over-year contract value growth from new and existing clients, 388% and 51% respectively.
